指南与共识血栓与止血

美国血液学会COVID-19患者抗凝血栓预防动态指南:2021年7月更新——出院后血栓预防

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis.
指南 / 共识 · Blood Adv · 2022-01-01

美国血液学会(ASH)基于GRADE方法制定动态指南,本次更新新增1条有条件推荐:对于出院且无疑似或确诊静脉血栓栓塞症(VTE)或抗凝其他指征的COVID-19患者,不推荐使用门诊抗凝预防。该推荐基于极低确定性证据,强调需高质量随机对照试验评估出院后血栓预防的作用。

要点

  • ASH动态指南新增1条有条件推荐:不推荐对出院且无VTE或抗凝指征的COVID-19患者使用门诊抗凝预防。
  • 该推荐基于极低确定性证据,强调需高质量随机对照试验评估出院后血栓预防。
  • 其他研究重点包括出院后COVID-19患者血栓和出血风险评估的更好证据。

核心结论

  • ASH小组对出院且无疑似或确诊VTE或抗凝其他指征的COVID-19患者,有条件推荐不使用门诊抗凝预防。
  • 该推荐基于极低确定性证据,强调需高质量随机对照试验评估出院后血栓预防的作用。

研究设计与样本

  • ASH成立多学科指南小组,包括3名患者代表,并采取措施减少利益冲突导致的偏倚。
  • 麦克马斯特大学GRADE中心支持指南制定过程,包括进行系统证据评价(截至2021年3月)。
  • 小组根据对临床医生和患者的重要性优先排序临床问题和结局,采用GRADE方法评估证据并制定推荐,推荐经过公开评论。

主要发现

  • 小组就1条额外推荐达成一致。
  • 该推荐为有条件推荐,反对对出院且无疑似或确诊VTE或抗凝其他指征的COVID-19患者使用门诊抗凝预防。

关键数值与推荐

  • 有条件推荐:反对对出院且无疑似或确诊VTE或抗凝其他指征的COVID-19患者使用门诊抗凝预防,基于极低确定性证据。

临床怎么用

  • 对于出院且无疑似或确诊VTE或抗凝其他指征的COVID-19患者,ASH有条件推荐不使用门诊抗凝预防。

局限性

  • 该推荐基于极低确定性证据。
  • 强调需高质量随机对照试验评估出院后血栓预防的作用。
  • 其他研究重点包括出院后COVID-19患者血栓和出血风险评估的更好证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19 who do not have confirmed or suspected VTE. METHODS: ASH formed a multidisciplinary guideline panel, including 3 patient representatives, and applied strategies to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including performing systematic evidence reviews (up to March 2021). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the grading of recommendations assessment, development, and evaluation (GRADE) approach to assess evidence and make recommendations, which were subject to public comment. RESULTS: The panel agreed on 1 additional recommendation. The panel issued a conditional recommendation against the use of outpatient anticoagulant prophylaxis in patients with COVID-19 who are discharged from the hospital and who do not have suspected or confirmed VTE or another indication for anticoagulation. CONCLUSIONS: This recommendation was based on very low certainty in the evidence, underscoring the need for high-quality randomized controlled trials assessing the role of postdischarge thromboprophylaxis. Other key research priorities include better evidence on assessing risk of thrombosis and bleeding outcomes in patients with COVID-19 after hospital discharge.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Adv. 2022. PMID: 34727173. doi:10.1182/bloodadvances.2021005945

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。